2014
DOI: 10.1007/s40273-014-0149-7
|View full text |Cite
|
Sign up to set email alerts
|

Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…Productivity costs can be measured using average wage figures (human capital methods) or replacement costs (friction cost models) . Friction costs are not recommended over the timescale of calculating incremental costs per day . We therefore used average wage rates, adjusted for on‐costs (employment costs less salary costs), to measure the productivity burden related to hospital admissions over 1 year.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Productivity costs can be measured using average wage figures (human capital methods) or replacement costs (friction cost models) . Friction costs are not recommended over the timescale of calculating incremental costs per day . We therefore used average wage rates, adjusted for on‐costs (employment costs less salary costs), to measure the productivity burden related to hospital admissions over 1 year.…”
Section: Methodsmentioning
confidence: 99%
“…19 Friction costs are not recommended over the timescale of calculating incremental costs per day. 21 We therefore used average wage rates, 22 adjusted for on-costs (employment costs less salary costs), 23 to measure the productivity burden related to hospital admissions over 1 year. We used the same rate for paid and unpaid work.…”
Section: Monetising Days Off Work and Informal Carementioning
confidence: 99%
“…The authors concluded that the inclusion of productivity costs significantly affected the incremental costs between treatments in a number of studies, and that studies which ignore these costs may poorly reflect the full societal costs (or savings) of an intervention. Further to this, the National Institute for Clinical Excellence in the UK (NICE) has recently announced that they will soon consider the societal benefit of pharmaceuticals, including their impact on productivity, in their assessment of treatments for reimbursement (Zhang and Anis 2014). The inclusion of this additional set of financial gains will enrich the information available to decision makers in allocating scarce resources between competing priorities and as such may provide valuable information to governments seeking to improve not only the health but also the productivity of the nation.…”
Section: Discussionmentioning
confidence: 99%
“…Testing criterion validity of iPCQ self-reported long-term absenteeism is feasible by validating against public registry data, which might be considered as a “golden standard”. Testing criterion validity of the remaining domains (presenteeism and costs related to unpaid work) poses significant challenges due to the lag of a “gold standard” or objective measures [ 9 ].…”
Section: Introductionmentioning
confidence: 99%